Ysios Capital Partners takes part in Kala Pharmaceuticals' closing of $68 Million Series C Financing

by Ysios Capital

Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering, and is backed by leading life sciences investors including Longitude Capital, OrbiMed, Vivo Capital, CAM Ca...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Grupo ONEtoONE desembarca con su fondo d...

by ONEtoONE Corporate Finance

ONEtoONE Asset Management ha realizado su quinta inversión fuera de n...

Photos Stream